GI Longevity
PrivateLast Round
Corporate Funding
Nov 20, 2023
Total Funding Raised
$30.78M
Company Overview
GI Longevity is a biotechnology company that develops microbiome-based anti-aging therapies and health functional foods.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Sports & Fitness
Business Model
B2C
Customer Profile
Hardware Sales, Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
GI Longevity Comparables
Compare GI Longevity with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| HealthBiome Inc. | 88% | |
| Enterobiome Inc. | 78% | |
| AtoGen Co., Ltd. | 78% | |
GI Longevity Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Corporate Funding | Nov 20, 2023 | ||||
| Series B | Jun 12, 2023 |
Market signals
Structured signals derived from secondary market and firmographic data.
- Nov 20, 2023
$2.3M round led by GI Innovation Inc.
- Jun 12, 2023
$2M round raised
GI Longevity Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about GI Longevity's valuation, stock price, and market status.